Oncolytics Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.5%.

Top 25 shareholders own 12.69% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.06%	Anson Group	3,814,299	CA$5.5m	-28.1%	0.65%
1.97%	Matthew Coffey	1,484,630	CA$2.1m	1,440%	no data
1.18%	Kirk Look	892,857	CA$1.3m	1,880%	no data
0.69%	Allison Hagerman	516,717	CA$744.1k	12,200%	no data
0.68%	Thomas Heineman	516,200	CA$743.3k	4,590%	no data
0.5%	Bernd Seizinger	380,126	CA$547.4k	20.7%	no data
0.35%	Wayne Pisano	264,941	CA$381.5k	39.5%	no data
0.31%	Morgan Stanley, Investment Banking and Brokerage Investments	231,385	CA$333.2k	270%	no data
0.26%	International Assets Investment Management, LLC	199,777	CA$287.7k	-0.83%	0.01%
0.26%	Angela Holtham	192,501	CA$277.2k	51.3%	no data
0.2%	Amy Levin	147,799	CA$212.8k	0%	no data
0.17%	Millennium Management LLC	127,842	CA$184.1k	-40%	no data
0.15%	Deborah Brown	114,211	CA$164.5k	133%	no data
0.15%	Citadel Advisors LLC	113,885	CA$164.0k	0%	no data
0.13%	Advisor Resource Council	100,000	CA$144.0k	0%	0.01%
0.081%	Canadian Imperial Bank of Commerce, Asset Management Arm	60,887	CA$87.7k	-0.04%	no data
0.074%	Wilcoxson Wealth Management	55,580	CA$80.0k	0%	no data
0.073%	RBC Dominion Securities Inc., Asset Management Arm	54,925	CA$79.1k	-1.44%	no data
0.066%	PSM Vermogensverwaltung GmbH	50,000	CA$72.0k	0%	0.44%
0.06%	Patricia S. Andrews	45,000	CA$64.8k	0%	no data
0.06%	James Parsons	45,000	CA$64.8k	0%	no data
0.06%	Jonathan M. Rigby	45,000	CA$64.8k	0%	no data
0.056%	Geode Capital Management, LLC	41,942	CA$60.4k	0%	no data
0.053%	Long Focus Capital Management LLC	40,000	CA$57.6k	0%	0.01%
0.05%	BMO Asset Management Corp.	37,582	CA$54.1k	15.1%	no data